Genetic Signatures Limited (ASX:GSS)
Australia
· Delayed Price · Currency is AUD 0.0950
-0.0050 (-5.00%)
At close: Mar 6, 2026
Genetic Signatures Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 16.08 | 15.9 | 9.77 | 16.94 | 35.42 | 28.28 | Upgrade
|
| Other Revenue | 3.85 | 3.85 | 4 | 4.57 | 0.08 | 0.1 | Upgrade
|
| Revenue | 19.94 | 19.75 | 13.77 | 21.51 | 35.5 | 28.38 | Upgrade
|
| Revenue Growth (YoY) | 6.82% | 43.47% | -36.00% | -39.39% | 25.06% | 105.43% | Upgrade
|
| Cost of Revenue | 9.81 | 9.25 | 7.91 | 11.83 | 13.6 | 11.25 | Upgrade
|
| Gross Profit | 10.12 | 10.51 | 5.86 | 9.68 | 21.9 | 17.14 | Upgrade
|
| Selling, General & Admin | 20.23 | 20.4 | 19.11 | 19.44 | 14.67 | 12.19 | Upgrade
|
| Other Operating Expenses | -0.13 | 2.34 | 3.09 | 3.31 | 2.58 | 1.99 | Upgrade
|
| Operating Expenses | 22.33 | 25.13 | 24.19 | 24.28 | 18.87 | 15.61 | Upgrade
|
| Operating Income | -12.21 | -14.63 | -18.33 | -14.59 | 3.03 | 1.53 | Upgrade
|
| Interest Expense | -0.07 | -0.09 | -0.04 | -0 | -0.02 | -0.04 | Upgrade
|
| Interest & Investment Income | 1.25 | 1.61 | 0.5 | 0.54 | 0.13 | 0.21 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | -0.09 | -0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.05 | - | - | - | 0.01 | 0.13 | Upgrade
|
| EBT Excluding Unusual Items | -11.07 | -13.11 | -17.86 | -14.05 | 3.06 | 1.76 | Upgrade
|
| Asset Writedown | -0.2 | -7 | - | - | - | - | Upgrade
|
| Pretax Income | -11.27 | -20.1 | -17.86 | -14.05 | 3.06 | 1.76 | Upgrade
|
| Net Income | -11.27 | -20.1 | -17.86 | -14.05 | 3.06 | 1.76 | Upgrade
|
| Net Income to Common | -11.27 | -20.1 | -17.86 | -14.05 | 3.06 | 1.76 | Upgrade
|
| Net Income Growth | - | - | - | - | 74.43% | - | Upgrade
|
| Shares Outstanding (Basic) | 230 | 227 | 165 | 143 | 143 | 143 | Upgrade
|
| Shares Outstanding (Diluted) | 230 | 227 | 165 | 143 | 145 | 146 | Upgrade
|
| Shares Change (YoY) | 12.76% | 37.18% | 15.25% | -1.40% | -0.16% | 14.76% | Upgrade
|
| EPS (Basic) | -0.05 | -0.09 | -0.11 | -0.10 | 0.02 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.09 | -0.11 | -0.10 | 0.02 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | 74.39% | - | Upgrade
|
| Free Cash Flow | -10.67 | -12.94 | -12.1 | -14.38 | 8.09 | -0.46 | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.06 | -0.07 | -0.10 | 0.06 | -0.00 | Upgrade
|
| Gross Margin | 50.78% | 53.19% | 42.53% | 45.01% | 61.69% | 60.38% | Upgrade
|
| Operating Margin | -61.22% | -74.06% | -133.14% | -67.83% | 8.54% | 5.38% | Upgrade
|
| Profit Margin | -56.53% | -101.78% | -129.74% | -65.32% | 8.63% | 6.19% | Upgrade
|
| Free Cash Flow Margin | -53.52% | -65.52% | -87.88% | -66.86% | 22.80% | -1.61% | Upgrade
|
| EBITDA | -10.42 | -12.67 | -16.53 | -13.07 | 4.3 | 2.56 | Upgrade
|
| EBITDA Margin | -52.27% | -64.14% | -120.05% | -60.74% | 12.12% | 9.02% | Upgrade
|
| D&A For EBITDA | 1.79 | 1.96 | 1.8 | 1.53 | 1.27 | 1.03 | Upgrade
|
| EBIT | -12.21 | -14.63 | -18.33 | -14.59 | 3.03 | 1.53 | Upgrade
|
| EBIT Margin | -61.22% | -74.05% | -133.14% | -67.83% | 8.54% | 5.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.